JPS6351335A - 肥満細胞脱顆粒抑制剤 - Google Patents

肥満細胞脱顆粒抑制剤

Info

Publication number
JPS6351335A
JPS6351335A JP61196347A JP19634786A JPS6351335A JP S6351335 A JPS6351335 A JP S6351335A JP 61196347 A JP61196347 A JP 61196347A JP 19634786 A JP19634786 A JP 19634786A JP S6351335 A JPS6351335 A JP S6351335A
Authority
JP
Japan
Prior art keywords
bbi
soybean
inhibitor
degranulation
trypsin inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61196347A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0586933B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Nobuhiko Katsunuma
信彦 勝沼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Oil Co Ltd
Original Assignee
Fuji Oil Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Oil Co Ltd filed Critical Fuji Oil Co Ltd
Priority to JP61196347A priority Critical patent/JPS6351335A/ja
Publication of JPS6351335A publication Critical patent/JPS6351335A/ja
Publication of JPH0586933B2 publication Critical patent/JPH0586933B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
JP61196347A 1986-08-20 1986-08-20 肥満細胞脱顆粒抑制剤 Granted JPS6351335A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61196347A JPS6351335A (ja) 1986-08-20 1986-08-20 肥満細胞脱顆粒抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61196347A JPS6351335A (ja) 1986-08-20 1986-08-20 肥満細胞脱顆粒抑制剤

Publications (2)

Publication Number Publication Date
JPS6351335A true JPS6351335A (ja) 1988-03-04
JPH0586933B2 JPH0586933B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-12-14

Family

ID=16356325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61196347A Granted JPS6351335A (ja) 1986-08-20 1986-08-20 肥満細胞脱顆粒抑制剤

Country Status (1)

Country Link
JP (1) JPS6351335A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003333A3 (en) * 1993-07-26 1995-03-23 Ucp Gen Pharma Ag Tryptase inhibitor
US5567425A (en) * 1993-11-30 1996-10-22 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5620888A (en) * 1994-12-29 1997-04-15 Lxr Biotechnology, Inc. Cell strains for use in identifying potentially therapeutically effective agents
US5637486A (en) * 1993-04-30 1997-06-10 Lxr Biotechnology Inc. Methods of identifying potentially therapeutically effective agents and cell strains for use therein
EP0841933A4 (en) * 1995-07-25 1998-08-05 Univ Pennsylvania BOWMAN BIRK INHIBITOR COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES
US6004579A (en) * 1995-09-14 1999-12-21 Lxr Biotechnology, Inc. Compositions which inhibit apoptosis, methods of making the compositions and uses thereof
WO2001062293A1 (fr) * 2000-02-22 2001-08-30 Suntory Limited Medicaments preventifs ou therapeutiques contenant des inhibiteurs de chymase en tant que principe actif, pour traiter diverses maladies associees a l'eosinophilie
US6949529B2 (en) 1997-03-19 2005-09-27 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
WO2009060915A1 (ja) * 2007-11-06 2009-05-14 San-Ei Gen F.F.I., Inc. 唾液分泌促進剤
WO2017150724A1 (ja) * 2016-03-03 2017-09-08 学校法人藤田学園 大豆アレルギーの抗原
JPWO2017150724A1 (ja) * 2016-03-03 2019-02-21 学校法人藤田学園 大豆アレルギーの抗原

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637486A (en) * 1993-04-30 1997-06-10 Lxr Biotechnology Inc. Methods of identifying potentially therapeutically effective agents and cell strains for use therein
US5681703A (en) * 1993-04-30 1997-10-28 Lxr Biotechnology Inc. Methods of identifying potentially therapeutically effective agents and cell strains for use therein
WO1995003333A3 (en) * 1993-07-26 1995-03-23 Ucp Gen Pharma Ag Tryptase inhibitor
AU694444B2 (en) * 1993-07-26 1998-07-23 Novartis Ag Tryptase inhibitor
US6306398B1 (en) 1993-11-30 2001-10-23 Lxr Biotechnology, Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US6656729B2 (en) 1993-11-30 2003-12-02 Sky High, Llc Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5635186A (en) * 1993-11-30 1997-06-03 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5624672A (en) * 1993-11-30 1997-04-29 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5620885A (en) * 1993-11-30 1997-04-15 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5635187A (en) * 1993-11-30 1997-06-03 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5567425A (en) * 1993-11-30 1996-10-22 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5620888A (en) * 1994-12-29 1997-04-15 Lxr Biotechnology, Inc. Cell strains for use in identifying potentially therapeutically effective agents
EP0841933A4 (en) * 1995-07-25 1998-08-05 Univ Pennsylvania BOWMAN BIRK INHIBITOR COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES
US6004579A (en) * 1995-09-14 1999-12-21 Lxr Biotechnology, Inc. Compositions which inhibit apoptosis, methods of making the compositions and uses thereof
US6949529B2 (en) 1997-03-19 2005-09-27 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US7259273B1 (en) 1998-03-18 2007-08-21 Goddard John G Compositions containing lysophosphotidic acids which inhabit apoptosis and uses thereof
US6677344B2 (en) 2000-02-22 2004-01-13 Daiichi Suntory Pharma Co., Ltd. Chymase inhibitor for the treatment of eosinophilia
WO2001062293A1 (fr) * 2000-02-22 2001-08-30 Suntory Limited Medicaments preventifs ou therapeutiques contenant des inhibiteurs de chymase en tant que principe actif, pour traiter diverses maladies associees a l'eosinophilie
WO2009060915A1 (ja) * 2007-11-06 2009-05-14 San-Ei Gen F.F.I., Inc. 唾液分泌促進剤
KR20180118128A (ko) * 2016-03-03 2018-10-30 호유 가부시키가이샤 대두 알레르기의 항원
WO2017150724A1 (ja) * 2016-03-03 2017-09-08 学校法人藤田学園 大豆アレルギーの抗原
JPWO2017150724A1 (ja) * 2016-03-03 2019-02-21 学校法人藤田学園 大豆アレルギーの抗原
JPWO2018158985A1 (ja) * 2016-03-03 2020-04-23 学校法人藤田学園 アレルギーの抗原およびそのエピトープ
KR20210144908A (ko) * 2016-03-03 2021-11-30 호유 가부시키가이샤 대두 알레르기의 항원
JP2022115966A (ja) * 2016-03-03 2022-08-09 学校法人藤田学園 アレルギーの抗原およびそのエピトープ
KR20220165796A (ko) * 2016-03-03 2022-12-15 호유 가부시키가이샤 대두 알레르기의 항원
JP2024079829A (ja) * 2016-03-03 2024-06-11 学校法人藤田学園 アレルギーの抗原およびそのエピトープ

Also Published As

Publication number Publication date
JPH0586933B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-12-14

Similar Documents

Publication Publication Date Title
Martodam et al. A rapid procedure for the large scale purification of elastase and cathepsin G from human sputum
Feinstein et al. A rapid method of purification of human granulocyte cationic neutral proteases: purification and further characterization of human granulocyte elastase
Proksch et al. The purification of the trypsin inhibitor from human pregnancy urine
KR940003751B1 (ko) 항혈액 응고물질의 제조방법
US3931399A (en) Process for isolating a fibrin-stabilizing factor
US6670455B1 (en) Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography
RIFKIN et al. Isolation of a protease inhibitor from tissues resistant to tumor invasion
US5258497A (en) Process for purifying annexines
US4485100A (en) Elastase inhibitors, a process for their preparation and medicaments containing these inhibitors
JPS6351335A (ja) 肥満細胞脱顆粒抑制剤
US5777081A (en) Process for producing an inter-alpha-trypsin inhibitor concentrate for therapeutic use and concentrate thus obtained
US7371418B2 (en) Method for controlling the yield and purity of proteinase inhibitor II during extraction
JPH03197495A (ja) 毒ヘビの毒ポリペプチド及び変異体
Wearne Factor Xa cleavage of fusion proteins: elimination of non-specific cleavage by reversible acylation
WO2003003835A1 (en) Method for controlling the yield and purity of proteinase inhibitor ii during extraction
US4177262A (en) Plasminogen compositions containing preactivated plasminogens with or without native plasminogens, process for making same, pharmaceutical compositions and control of blood clots
Bagge et al. Purification and characterization of an inhibitor of plasminogen activation from post-traumatic patients
Pierce Purification of mammalian kallikreins, kininogens, and kinins
US4479937A (en) Process of treating inflammation with human urinary thiol protease inhibitor
WO2003003836A1 (en) Method for the elimination of kunitz and bowman-birk trypsin inhibitors and carboxydase inhibitor from potato proteins
US3951939A (en) Polypeptides, process for their manufacture and their use as polyvalent isoinhibitors
Paulssen et al. Purification of the antihemophilic factor by gel filtration on agarose
Srivastava et al. Purification and properties of a protein from bovine lens which inhibits trypsin and two endogenous lens proteinases
ASTRUP et al. Purification of Renin by Means of Protein-Precipitating Agents
AU781741B2 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or mixture of both proteins by means of ion-exchange chromatography

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees